The roles of dopamine and glutamate within neurotransmission have been seen as the underlying hypothesis of schizophrenia. Surplus dopamine neurotransmission has been suggested as the cause for psychosis, with dopamine D2 receptor blockers being current and effective treatment (Seeman, 2009). Research has also suggested that excess or insufficient glutamate activity may also cause symptoms of schizophrenia (“The glutamate hypothesis,” 2009). Correspondingly, the roles of the neurotransmitters serotonin, norepinephrine and dopamine have also been shown to have an association with depressive disorder (McCrae & Khan,
The roles of dopamine and glutamate within neurotransmission have been seen as the underlying hypothesis of schizophrenia. Surplus dopamine neurotransmission has been suggested as the cause for psychosis, with dopamine D2 receptor blockers being current and effective treatment (Seeman, 2009). Research has also suggested that excess or insufficient glutamate activity may also cause symptoms of schizophrenia (“The glutamate hypothesis,” 2009). Correspondingly, the roles of the neurotransmitters serotonin, norepinephrine and dopamine have also been shown to have an association with depressive disorder (McCrae & Khan,